congo red has been researched along with Disease Models, Animal in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.32) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 23 (56.10) | 29.6817 |
| 2010's | 7 (17.07) | 24.3611 |
| 2020's | 6 (14.63) | 2.80 |
| Authors | Studies |
|---|---|
| Haratake, M; Hori, M; Mori, H; Nakayama, M; Ono, M; Tomiyama, T | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Hagimori, M; Haratake, Y; Minaki, K; Mukai, T; Munekane, M; Sano, K; Tsuchiya, M; Yamasaki, T | 1 |
| Amoli, MM; Azarfar, K; Ebrahim-Habibi, A; Hayati-Roodbari, N; Yaghmaei, P | 1 |
| Beladiya, J; Modi, K; Pande, S; Parmar, S; Patel, B; Patel, C; Patel, S; Shah, S; Sheth, D; Vyas, A | 1 |
| Amiri, I; Ghanbari, A; Gholami Mahmoudian, Z; Komaki, A; Rashidi, I | 1 |
| Girigoswami, A; Girigoswami, K; Metkar, SK; Vijayashree, R | 1 |
| Johnstone, DM; Marotte, L; Purushothuman, S; Stone, J; Stowe, S | 1 |
| Diao, XW; Fa, HB; Li, S; Yin, W; Zhang, D; Zhou, JT | 1 |
| Dai, F; Fan, Z; Hu, B; Ma, G; Tang, Q; Zhang, X | 1 |
| Murakami, T; Nakazawa, Y; Suzuki, K; Tsukawaki, S | 1 |
| Ait-Ghezala, G; Ganey, C; Ganey, N; Laporte, V; Mullan, M; Volmar, CH; Wood, M | 1 |
| Levine, H; Walker, LC | 1 |
| Lundmark, K; Westermark, GT; Westermark, P | 1 |
| Cui, W; Feng, XY; Gu, B; He, H; Li, J; Li, S; Liang, CM; Qi, Z; Zhou, G | 1 |
| Esmailzade, B; Hoseini, SM; Mortazavi, P; Nobakht, M; Omidzahir, S; Rahbar Rooshandel, N; Sohrabi, I | 1 |
| Bacskai, BJ; Debnath, ML; Frosch, MP; Holt, DP; Hyman, BT; Kajdasz, ST; Klunk, WE; Mathis, CA; McLellan, ME; Wang, Y | 1 |
| Abe, K; Harigaya, Y; Ikeda, M; Kawarabayashi, T; Matsubara, E; Naito, M; Nakazato, Y; Sasaki, A; Shoji, M | 1 |
| Mahlke, C; Sánchez, I; Yuan, J | 1 |
| Ando, Y; Doh-ura, K; Haraoka, K; Ishikawa, K; Ishizaki, T; Katsuragi, S; Nakagawa, K; Nakamura, M; Sasaki, Y; Sasamoto, K; Sun, X; Takesako, K; Tanoue, Y; Terazaki, H | 1 |
| Di Carlo, G; Gordon, MN; Mori, S; Munireddy, S; van Zijl, PC; Yarowsky, P; Zhang, J | 1 |
| Iwai, A; Kawabata, S; Noda-Saita, K; Okada, M; Shitaka, Y; Terai, K; Tsukamoto, M; Yamaguchi, T | 1 |
| Cechetto, DF; Hachinski, VC; Whitehead, SN | 1 |
| Crowther, DC; Curry, JA; Duthie, FA; Gubb, DC; Kinghorn, KJ; Lomas, DA; Miranda, E; Page, R | 1 |
| Gruys, E; Rofina, JE; Secrève, M; Toussaint, MJ; van der Meer, I; van der Spek, A; van Ederen, AM; Van Eerdenburg, FJ | 1 |
| Collinge, J; Trevitt, CR | 1 |
| Fukunishi, S; Kamae, S; Yoh, K; Yoshiya, S | 1 |
| Bozon, B; Delatour, B; Delzescaux, T; Dhenain, M; Dubois, A; Faure, A; Feki, A; Hantraye, P; Teboul, O | 1 |
| Delobel, P; Fraser, G; Ghetti, B; Goedert, M; Lavenir, I; Velasco, A | 1 |
| Araki, S; Takahashi, K; Yamamura, K; Yi, S | 1 |
| Blumenthal, HT; Naidu, RG; Premachandra, BN; Williams, IK | 1 |
| Bian, F; Callahan, MJ; Durham, RA; Kane, MD; Lipinski, WJ; Roher, AE; Schwarz, RD; Walker, LC | 1 |
| Bales, KR; DiCarlo, G; Gordon, MN; Morgan, D; Nilsson, LN; Paul, SM; Potter, H | 1 |
| Clark, A; Jaikaran, ET | 1 |
| Akagi, T; Hashikawa, T; Kikuchi, N; Matsuda, K; Murayama, M; Murayama, O; Nakao, S; Park, JM; Sato, S; Sun, X; Takashima, A; Tanemura, K; Yamaguchi, H; Yoshiike, Y | 1 |
| Bates, GP; Hockly, E; Klunk, WE; Li, XJ; Mahal, A; Murray, KD; Portier, R; Smith, DL; Wanker, E; Woodman, B | 1 |
| Mallory, M; Mante, M; Masliaha, E; Rockenstein, E; Sisk, A | 1 |
| Elder, RO; Keen, JE; Uhlich, GA | 1 |
| Bennett, M; Cathcart, ES; Scheinberg, MA | 1 |
| Powers, JM; Terry, RD; Wisniewski, H | 1 |
| Dourov, N | 1 |
3 review(s) available for congo red and Disease Models, Animal
| Article | Year |
|---|---|
A systematic review of prion therapeutics in experimental models.
Topics: Animals; Anti-Bacterial Agents; Anticoagulants; Antimalarials; Antiviral Agents; Cattle; Congo Red; Creutzfeldt-Jakob Syndrome; Disease Models, Animal; Encephalopathy, Bovine Spongiform; Glycosaminoglycans; Humans; Immunotherapy; Polyamines; Prion Diseases; PrPC Proteins; Tetracyclines | 2006 |
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
Topics: Amino Acid Sequence; Amyloid; Amyloidosis; Animals; Congo Red; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Islets of Langerhans; Microscopy, Electron; Models, Molecular; Molecular Sequence Data; Protein Conformation; Protein Folding; Protein Precursors; Species Specificity | 2001 |
[Amyloidosis: the present state of the question].
Topics: Age Factors; Amyloid; Amyloidosis; Animals; Antigens; Belgium; Congo Red; Disease Models, Animal; Dogs; Europe; Guinea Pigs; Horses; Humans; Immunoglobulins; Mice; Microscopy, Electron; Plasma Cells; Reticulocytes; Staining and Labeling | 1974 |
38 other study(ies) available for congo red and Disease Models, Animal
| Article | Year |
|---|---|
Structure-activity relationship of chalcones and related derivatives as ligands for detecting of beta-amyloid plaques in the brain.
Topics: Alzheimer Disease; Animals; Binding, Competitive; Brain; Chalcones; Disease Models, Animal; Ligands; Mice; Plaque, Amyloid; Structure-Activity Relationship | 2007 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Development of a radioiodinated thioflavin-T-Congo-red hybrid probe for diagnosis of systemic amyloidosis.
Topics: Amyloidosis; Animals; Autoradiography; Benzothiazoles; Congo Red; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Development; Female; Iodine Radioisotopes; Mice; Mice, Inbred ICR; Molecular Structure; Radiopharmaceuticals; Structure-Activity Relationship | 2022 |
Local Insulin-Derived Amyloidosis Model Confronted with Silymarin: Histological Insights and Gene Expression of MMP, TNF-α, and IL-6.
Topics: Amyloid; Amyloidosis; Animals; Congo Red; Disease Models, Animal; Gene Expression; Insulin; Insulin, Regular, Human; Interleukin-6; Matrix Metalloproteinases; Rats; Silymarin; Tumor Necrosis Factor-alpha | 2022 |
Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Congo Red; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Glucagon-Like Peptide 1; Inflammation; Male; Maze Learning; Memory Disorders; Ocimum sanctum; Plant Extracts; Rats; Rats, Wistar; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
The effect of minocycline on beta-amyloid-induced memory and learning deficit in male rats: A behavioral, biochemical, and histological study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Antioxidants; Avoidance Learning; Congo Red; Disease Models, Animal; Hippocampus; Male; Minocycline; Peptide Fragments; Plaque, Amyloid; Rats | 2022 |
Attenuation of subcutaneous insulin induced amyloid mass in vivo using Lumbrokinase and Serratiopeptidase.
Topics: Animals; Benzothiazoles; Congo Red; Disease Models, Animal; Endopeptidases; Injection Site Reaction; Injections, Subcutaneous; Insulin; Male; Microscopy, Fluorescence; Microscopy, Polarization; Peptide Hydrolases; Plaque, Amyloid; Protein Aggregation, Pathological; Rats; Rats, Wistar; Subcutaneous Tissue | 2020 |
The response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Benzothiazoles; Brain; Brain Injuries; Cell Death; Cerebral Cortex; Congo Red; Disease Models, Animal; Female; Ferrocyanides; Heme; Hemorrhage; Hippocampus; Humans; Immunohistochemistry; Male; Neocortex; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins; Temporal Lobe; Thiazoles; Wounds, Penetrating | 2013 |
The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO.
Topics: 2-Naphthylamine; Acrylonitrile; Alzheimer Disease; Animals; Case-Control Studies; Coloring Agents; Congo Red; Contrast Media; Disease Models, Animal; Ferrocyanides; Hippocampus; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Amyloid; Rats; Spectrometry, Fluorescence | 2015 |
Nanotheranostics: Congo Red/Rutin-MNPs with Enhanced Magnetic Resonance Imaging and H2O2-Responsive Therapy of Alzheimer's Disease in APPswe/PS1dE9 Transgenic Mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cell Line, Tumor; Congo Red; Contrast Media; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Humans; Hydrogen Peroxide; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice, Transgenic; Neuroprotective Agents; Oxidative Stress; Plaque, Amyloid; Presenilin-1; Rutin; Theranostic Nanomedicine | 2015 |
Studies on the potential risk of amyloidosis from exposure to silk fibroin.
Topics: Amyloid; Amyloidosis; Animals; Congo Red; Disease Models, Animal; Female; Fibroins; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Powders; Serum Amyloid A Protein | 2016 |
CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; CD40 Antigens; CD40 Ligand; Cell Line, Tumor; Chromobox Protein Homolog 5; Coloring Agents; Congo Red; Cyclin-Dependent Kinase 5; Disease Models, Animal; Down-Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurites; Neurofibrillary Tangles; Phosphorylation; Phosphotransferases; Plaque, Amyloid; tau Proteins | 2008 |
Molecular polymorphism of Abeta in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Benzothiazoles; Binding Sites; Binding, Competitive; Coloring Agents; Congo Red; Diagnostic Imaging; Disease Models, Animal; Humans; Ligands; Molecular Probes; Pathology, Molecular; Plaque, Amyloid; Predictive Value of Tests; Protein Isoforms; Thiazoles | 2010 |
Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model.
Topics: Amyloid; Amyloidosis; Animals; Benzothiazoles; Coloring Agents; Congo Red; Disease Models, Animal; Female; Humans; Inflammation; Mice; Peptides; Spleen; Thiazoles; Time Factors | 2009 |
Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Topics: Albumins; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Congo Red; Contrast Media; Disease Models, Animal; Drug Combinations; Gadolinium DTPA; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Molecular Probes; Neurofibrillary Tangles; Plaque, Amyloid | 2010 |
Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Cell Count; Cell Death; Cerebral Cortex; Congo Red; Disease Models, Animal; Hippocampus; In Situ Nick-End Labeling; Male; Maze Learning; Neurons; Rats; Rats, Wistar; Staining and Labeling | 2011 |
Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene; Benzene Derivatives; Binding, Competitive; Blood-Brain Barrier; Carbon Radioisotopes; Coloring Agents; Congo Red; Disease Models, Animal; Imaging, Three-Dimensional; Male; Mice; Mice, Transgenic; Microscopy; Peptide Fragments; Plaque, Amyloid; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Stilbenes | 2002 |
Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain; Congo Red; Disease Models, Animal; Female; Histocompatibility Antigens Class II; Immunohistochemistry; Macrophage-1 Antigen; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Microglia; Microscopy, Immunoelectron; Neurites; Neurofibrillary Tangles; Plaque, Amyloid; Receptor, Macrophage Colony-Stimulating Factor | 2002 |
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.
Topics: Adenosine Triphosphate; Animals; Caspases; Cell Death; Congo Red; Disease Models, Animal; Enzyme Activation; HeLa Cells; Humans; Huntington Disease; Mice; Mice, Transgenic; Neurodegenerative Diseases; Peptides; Protein Binding; Protein Structure, Quaternary; Recombinant Fusion Proteins; Survival Rate; Trinucleotide Repeat Expansion; Weight Loss | 2003 |
A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo.
Topics: Adult; Amyloid; Amyloidosis; Animals; Congo Red; Disease Models, Animal; Female; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice; Middle Aged; Prealbumin; Staining and Labeling; Styrenes | 2003 |
Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.
Topics: Alzheimer Disease; Amyloid; Animals; Artifacts; Brain; Cerebral Cortex; Coloring Agents; Congo Red; Corpus Callosum; Disease Models, Animal; Hippocampus; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Mesencephalon; Mice; Mice, Transgenic; Putamen | 2004 |
Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Congo Red; Disease Models, Animal; Female; Humans; Immunohistochemistry; Mice; Mice, Transgenic; Neurites; Plaque, Amyloid; tau Proteins | 2004 |
Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain; Brain Chemistry; Brain Ischemia; Coloring Agents; Congo Red; Disease Models, Animal; Encephalitis; Endothelins; Gliosis; Immunohistochemistry; Injections; Learning; Male; Motor Skills; Peptide Fragments; Rats; Rats, Wistar | 2005 |
Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Congo Red; Disease Models, Animal; Drosophila melanogaster; Inclusion Bodies; Longevity; Movement Disorders; Nerve Degeneration; Nervous System; Neurons; Neuroprotective Agents; Peptide Fragments; Transgenes; Vacuoles | 2005 |
Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Aging; Aldehydes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Atrophy; Behavior, Animal; Cerebral Cortex; Cognition Disorders; Congo Red; Demyelinating Diseases; Deoxyguanosine; Disease Models, Animal; Dogs; Female; Immunohistochemistry; Lipofuscin; Male; Statistics, Nonparametric | 2006 |
Beta 2-microglobulin amyloid deposit in HLA-B27 transgenic rats.
Topics: Amyloid; Animals; Animals, Genetically Modified; Arthritis, Experimental; beta 2-Microglobulin; Collagen Type II; Congo Red; Disease Models, Animal; Female; Gene Expression Regulation; HLA-B27 Antigen; Microscopy, Electron, Transmission; Rats; Rats, Inbred F344; Renal Dialysis; Time Factors | 2007 |
A standardized method to automatically segment amyloid plaques in Congo Red stained sections from Alzheimer transgenic mice.
Topics: Algorithms; Alzheimer Disease; Animals; Artificial Intelligence; Brain; Colorimetry; Congo Red; Contrast Media; Disease Models, Animal; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Mice, Transgenic; Pattern Recognition, Automated; Plaque, Amyloid; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene].
Topics: Animals; Congo Red; Disease Models, Animal; Fluorescent Dyes; Histocytochemistry; Humans; Inclusion Bodies; Mice; Mice, Transgenic; Spinal Cord; Styrenes; tau Proteins; Tauopathies | 2008 |
Transgenic mouse model of familial amyloidotic polyneuropathy type I: its production, biological features, and usefulness.
Topics: Amyloid; Amyloid Neuropathies; Amyloidosis; Animals; Congo Red; Disease Models, Animal; Humans; Mice; Mice, Mutant Strains; Mice, Transgenic; Microscopy, Polarization; Myocardium; Prealbumin | 1995 |
Cerebral vascular amyloid deposition in rabbits with induced thyroglobulin immunity.
Topics: Amyloidosis; Animals; Basement Membrane; Brain; Cell Membrane; Cerebral Amyloid Angiopathy; Cerebrovascular Disorders; Choroid Plexus; Congo Red; Disease Models, Animal; Male; Rabbits; Thyroglobulin | 1995 |
Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antigen-Antibody Reactions; Cerebral Arteries; Coloring Agents; Congo Red; Disease Models, Animal; Encephalitis; Female; Hippocampus; Humans; Injections, Intraventricular; Male; Mice; Mice, Transgenic; Nerve Degeneration | 2000 |
Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.
Topics: alpha 1-Antichymotrypsin; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Astrocytes; Congo Red; Crosses, Genetic; Disease Models, Animal; Glial Fibrillary Acidic Protein; Head Injuries, Penetrating; Hippocampus; Humans; Mice; Mice, Transgenic; Organ Specificity; Plaque, Amyloid; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Protein Structure, Secondary | 2001 |
Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.
Topics: Animals; Benzothiazoles; Brain; Cerebral Cortex; Coloring Agents; Congo Red; Disease Models, Animal; Female; Gene Expression Regulation; Hippocampus; Humans; Immunohistochemistry; Male; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Microscopy, Electron; Mutation, Missense; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurons; Protein Structure, Secondary; tau Proteins; Thiazoles; Transfection; Ubiquitin | 2001 |
Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.
Topics: Animals; Benzoates; Biphenyl Compounds; Cells, Cultured; Coloring Agents; Congo Red; Creatine; Cysteine Endopeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Energy Metabolism; Female; Hippocampus; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nuclear Proteins; Organ Culture Techniques; Peptides; Proteasome Endopeptidase Complex; Protein Folding; Trinucleotide Repeat Expansion; Ubiquitin | 2001 |
Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzothiazoles; Brain; Congo Red; Disease Models, Animal; Gene Expression Regulation, Developmental; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Microscopy, Electron; Mutagenesis, Insertional; Mutation; Neurites; Neurons; Peptide Fragments; Plaque, Amyloid; Presynaptic Terminals; Promoter Regions, Genetic; Thiazoles | 2001 |
Variations in the csgD promoter of Escherichia coli O157:H7 associated with increased virulence in mice and increased invasion of HEp-2 cells.
Topics: Animals; Chlorocebus aethiops; Coloring Agents; Congo Red; Disease Models, Animal; Electrophoresis, Gel, Pulsed-Field; Escherichia coli Infections; Escherichia coli O157; Escherichia coli Proteins; Genetic Variation; Gentamicins; Humans; Mice; Promoter Regions, Genetic; Shiga Toxin; Trans-Activators; Tumor Cells, Cultured; Vero Cells; Virulence | 2002 |
Casein-induced experimental amyloidosis. V. The response of lymphoid organs to T and B mitogens.
Topics: Amyloidosis; Animals; B-Lymphocytes; Bone Marrow; Caseins; Concanavalin A; Congo Red; Disease Models, Animal; Female; Injections, Subcutaneous; Lectins; Lipopolysaccharides; Lymph Nodes; Lymphocyte Activation; Lymphoid Tissue; Mice; Mice, Inbred Strains; Mitogens; Spleen; Staining and Labeling; T-Lymphocytes; Thymus Gland | 1975 |
Lack of amyloidosis and renal disease in A strain mice.
Topics: Adrenal Glands; Amyloidosis; Animals; Congo Red; Connective Tissue; Connective Tissue Cells; Disease Models, Animal; False Positive Reactions; Female; Histocytochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred A; Rodent Diseases; Tongue | 1976 |